Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04298034 · ClinicalTrials.gov registry record · Phase 3
Preeclampsia Postpartum Antihypertensive Treatment
A Phase 3 study of Preeclampsia and Hypertension in Pregnancy, sponsored by Medical College of Wisconsin.
- Active
- Registry status
- Phase 3
- Development phase
- 300
- Enrollment target
- 1
- Study location
NCT04298034 is a Phase 3 study of Preeclampsia and Hypertension in Pregnancy that is active but no longer recruiting, run by Medical College of Wisconsin. The registered enrollment target is 300 participants, below the 1,274-participant average among 39 other Preeclampsia trials with a reported enrollment target (76% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04298034, a Phase 3 study of Preeclampsia and Hypertension in Pregnancy, is active but no longer recruiting, sponsored by Medical College of Wisconsin.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 3
- Development phase
- 300 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to compare whether antihypertensive treatment in the postpartum period decreases postpartum hypertension and its associated maternal morbidity, including risk of readmission and healthcare utilization in comparison with no treatment. Women with preeclampsia diagnosed during the antepartum, intrapartum or postpartum period will be randomized to either initiate antihypertensive treatment or standard of care. We hypothesize that postpartum antihypertensive treatment of patients with preeclampsia will decrease risk of hospital readmission, healthcare utilization and the number of severe range blood pressures at postpartum follow-up visits.
Conditions Studied
Interventions
- DRUG Labetalol, Nifedipine
Study Locations (1)
Wisconsin
- Medical College of Wisconsin-Froedtert Hospital - Milwaukee
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2020-07-17 |
| Est. Completion | 2025-12-30 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04298034
The ClinicalTrials.gov registry entry for NCT04298034 describes a study currently listed as active not recruiting, categorized as Phase 3. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,274-participant average among 39 other Preeclampsia trials with a reported enrollment target (76% lower). The listed sponsor is Medical College of Wisconsin, which has 447 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Preeclampsia appearing as the primary indexed condition, and to 1 intervention - of which Labetalol, Nifedipine is the first listed.
NCT04298034 reports 1 study location spanning 1 distinct geographic area - top geographies include Wisconsin.
Frequently Asked Questions
What is clinical trial NCT04298034 about?
NCT04298034 is a clinical study titled "Preeclampsia Postpartum Antihypertensive Treatment". The goal of this study is to compare whether antihypertensive treatment in the postpartum period decreases postpartum hypertension and its associated maternal morbidity, including risk of readmission and healthcare utilization in comparison with no treatment. Women with preeclampsia diagnosed during...
What is the current status of trial NCT04298034?
This trial is currently active not recruiting. It is a Phase 3 study. The enrollment target is 300 participants. The study started on 2020-07-17. Estimated completion is 2025-12-30.
What conditions does trial NCT04298034 study?
This clinical trial studies the following conditions: Preeclampsia, Hypertension in Pregnancy.
What interventions are being tested in trial NCT04298034?
The interventions under investigation include: Labetalol, Nifedipine (DRUG).
Who is sponsoring clinical trial NCT04298034?
This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04298034 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Preeclampsia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Spironolactone to Improve Pregnancy-Associated Hypertension Trajectories
RECRUITING · Phase 2
-
Eliminating Severe Maternal Morbidity With Heart Health Doulas Trial
RECRUITING · NA
-
Daily Aspirin Treatment After Preeclampsia
RECRUITING · Early Phase 1
-
Optimizing Cardiovascular Preventive Care for Women Following Hypertensive Disorders of Pregnancy
RECRUITING · NA
-
Exosome Cargo From Preeclampsia Patients
RECRUITING
-
Prenatal Aspirin and Postpartum Vascular Function
RECRUITING · Early Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.